Related Experiment Video
Updated: Jul 29, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Contrast-induced nephropathy: epidemiology and prevention
1Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia. sean.bagshaw@austin.org.au
Insights
Preventing contrast-induced nephropathy (CIN) requires careful patient management. While hydration and specific contrast agents are effective, many other interventions lack strong evidence for preventing this iatrogenic kidney failure.
Area of Science:
- Nephrology
- Radiology
- Internal Medicine
Background:
- Contrast-induced nephropathy (CIN) is a significant cause of iatrogenic acute kidney injury.
- CIN increases risks of renal replacement therapy, prolonged hospitalization, and mortality.
- Risk factors include pre-existing kidney disease, diabetes, heart failure, and contrast volume.
Purpose of the Study:
- To critically appraise the evidence for prophylactic interventions against CIN.
- To identify effective and ineffective strategies for CIN prevention.
Main Methods:
- Systematic review and critical appraisal of existing clinical studies on CIN prevention.
- Evaluation of evidence for various prophylactic agents and procedures.
Main Results:
- Intravenous hydration and use of nonionic iso-osmolar contrast media are consistently effective.
- N-acetylcysteine shows potential benefit in high-risk patients; adenosine antagonists require further study.
- Inadequate evidence exists for hemofiltration, atrial natriuretic peptides, calcium channel blockers, prostaglandins, diuretics, dopamine, fenoldopam, captopril, or endothelin receptor antagonists.
Conclusions:
- Few interventions demonstrate quality evidence for reducing CIN incidence.
- Minimizing contrast volume and addressing risk factors are crucial.
- No therapy is proven effective once CIN is established.
Abstract:
Contrast-induced nephropathy (CIN) is a leading cause of iatrogenic acute kidney failure. Periprocedural CIN results in a greater risk of requiring renal replacement therapy, prolonged hospitalization, excessive health care costs, potential long term kidney impairment and mortality. Identified risk factors for CIN include premorbid chronic kidney disease, diabetes mellitus, congestive heart failure, critical illness and volume of administered contrast media. Prophylactic interventions for the prevention of CIN remain controversial and uncertain. In this review we critically appraise the evidence for prevention of CIN. In general, every attempt should be made to correct underlying volume depletion, discontinue potential nephrotoxins, reverse any acute kidney dysfunction or when not possible, consider delay of procedure or an alternative modality for imaging. A minimum volume of contrast media should be employed, including going left ventriculogram and performing staged procedures if applicable. There are few interventions with quality evidence for reducing the incidence of CIN. procedure hydration and the use of nonionic iso-osmolar contrast media have consistently demonstrated efficacy. For patients at high risk, there is evidence to suggest benefit with N-acetylcysteine. Clinical studies with adenosine antagonists are encouraging; however, further confirmatory trials are required. Based on the available studies, there is inadequate evidence for the routine use of hemofiltration, atrial natriuretic peptides, calcium channel blockers, or prostaglandins. There is no evidence to support prophylaxis with diuretic therapy, forced diuresis, low dose dopamine, fenoldopam, captopril, or endothelin receptor antagonists. Despite recent advances in the epidemiology, pathophysiology and natural history of CIN, few effective prophylactic or therapeutic interventions have conclusively demonstrated evidence for a reduction in CIN incidence and no therapy has proven efficacious once CIN is established.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy

